REACT-2 is a large-scale national surveillance study in England. It examines the prevalence of antibodies to SARS-CoV-2 in adults the community. Participants complete finger prick self-testing at home (lateral flow immunoassay) and a questionnaire.
sars-cov-2 covid-19 antibody prevalence surveillance